Form 4: SpringWorks Therapeutics CEO Saqib Islam Sells Shares

SpringWorks Therapeutics CEO Saqib Islam sold shares of common stock on February 20, 2025, under a pre-arranged trading plan.

Summary

• On February 20, 2025, Saqib Islam, the CEO of SpringWorks Therapeutics, sold shares of the company's common stock.
• The sales were executed under a trading plan established on February 29, 2024, in accordance with Rule 10b5-1.
• A total of 24,260 shares were sold at a weighted average price of $60.1011, with individual prices ranging from $59.90 to $60.83.
• An additional 5,068 shares were sold at a weighted average price of $61.2368, with individual prices ranging from $60.93 to $61.57.
• Following the transactions, Islam directly owns 1,034,625 shares of SpringWorks Therapeutics common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating insider selling under a pre-arranged plan. It's neutral in sentiment as it simply reports transactions.

Industry Context

Insider selling is a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares over time while avoiding concerns about trading on non-public information. The market typically views such sales in the context of the individual's overall holdings and the reasons for establishing the trading plan.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, although the existence of a pre-arranged trading plan mitigates this concern.

Key Dates

Keywords

SpringWorks Therapeutics, SWTX, Saqib Islam, CEO, stock sale, Form 4, Rule 10b5-1, insider trading